Semaglutide & Empagliflozin for Obesity-Related Cognitive Impairment
Obesity can lead to impaired learning, memory and cognitive decline, but the underlying mechanisms are not fully understood. A new mouse study reveals how obesity disrupts key signaling pathways in the brain, and shows the potential of two diabetes drugs, sema…
Read article